{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:14:46Z","timestamp":1794060886894,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ama121001"],"award-info":[{"award-number":["JP22ama121001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtn.2023.06.023","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:29:03Z","timestamp":1688419743000},"page":"210-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4130-3740","authenticated-orcid":false,"given":"Kazuto","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kappei","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.06.023_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/humu.20813","article-title":"Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases","volume":"30","author":"Mitchell","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2023.06.023_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1089-3261(05)70143-4","article-title":"Urea cycle disorders","volume":"4","author":"Burton","year":"2000","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.omtn.2023.06.023_bib3","first-page":"160","article-title":"Hyperammonemia in pediatric clinics: a review of ornithine transcarbamylase deficiency (OTCD) based on our case studies","volume":"47","author":"Matsuda","year":"2004","journal-title":"JMAJ"},{"key":"10.1016\/j.omtn.2023.06.023_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jgg.2015.04.003","article-title":"Genotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation update","volume":"42","author":"Caldovic","year":"2015","journal-title":"J.\u00a0Genet. Genomics"},{"key":"10.1016\/j.omtn.2023.06.023_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M","article-title":"Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype","volume":"93","author":"McCullough","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtn.2023.06.023_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-007-0429-x","article-title":"Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential","volume":"30","author":"Arranz","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2023.06.023_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2023.06.023_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10528-017-9825-6","article-title":"Aminoacidopathies: prevalence, etiology, screening, and treatment options","volume":"56","author":"Wasim","year":"2018","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.omtn.2023.06.023_bib9","series-title":"Swaiman's Pediatric Neurology, 6th Edition Principles and Practice","first-page":"298","article-title":"Inborn errors of urea synthesis","author":"Nagamani","year":"2017"},{"key":"10.1016\/j.omtn.2023.06.023_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ymgme.2008.04.011","article-title":"Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular analysis in complex presentations of classical diseases","volume":"94","author":"Deardorff","year":"2008","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2023.06.023_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1297\/cpe.19.25","article-title":"Contiguous Xp11.4 Gene deletion leading to ornithine transcarbamylase deficiency detected by high-density single-nucleotide array","volume":"19","author":"Ono","year":"2010","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.omtn.2023.06.023_bib12","first-page":"332","article-title":"X-chromosome inactivation in human liver: confirmation of X-linkage of ornithine transcarbamylase","volume":"28","author":"Ricciuti","year":"1976","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2023.06.023_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17425255.2017.1262843","article-title":"An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease","volume":"13","author":"De Las Heras","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.omtn.2023.06.023_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1023\/A:1005317909946","article-title":"Liver transplantation for the treatment of urea cycle disorders","volume":"21","author":"Whitington","year":"1998","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2023.06.023_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.omtm.2020.11.005","article-title":"Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector","volume":"20","author":"De Sabbata","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2023.06.023_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtm.2021.09.005","article-title":"Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys","volume":"23","author":"Baruteau","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2023.06.023_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/CVI.05107-11","article-title":"Adeno-associated virus antibody profiles in newborns, children, and adolescents","volume":"18","author":"Calcedo","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.omtn.2023.06.023_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2174\/1389201015666140327141710","article-title":"Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations","volume":"14","author":"Selot","year":"2014","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.omtn.2023.06.023_bib19","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.ymthe.2021.08.031","article-title":"AAV integration in human hepatocytes","volume":"29","author":"Dalwadi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.06.023_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2017.12.024","article-title":"Targeted mRNA therapy for ornithine transcarbamylase deficiency","volume":"26","author":"Prieve","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.06.023_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2017.01.016","article-title":"Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates","volume":"519","author":"Suzuki","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2023.06.023_bib22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.omtn.2021.08.023","article-title":"Irf5 siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury","volume":"25","author":"Kawase","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.06.023_bib23","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/TP.0000000000004207","article-title":"Novel complement C5 small-interfering RNA lipid nanoparticle prolongs graft survival in a hypersensitized rat kidney transplant model","volume":"106","author":"Ishigooka","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.omtn.2023.06.023_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.omtn.2023.01.005","article-title":"Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis","volume":"31","author":"Kuboi","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.06.023_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","article-title":"Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates","volume":"30","author":"Suzuki","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.06.023_bib26","doi-asserted-by":"crossref","first-page":"34247","DOI":"10.1074\/jbc.273.51.34247","article-title":"1.85-\u00c5 resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency","volume":"273","author":"Shi","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.06.023_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1097-0134(20000601)39:4<271::AID-PROT10>3.0.CO;2-E","article-title":"Crystal structure of human ornithine transcarbamylase complexed with carbamoyl phosphate and L-norvaline at 1.9\u00a0\u00c5 resolution","volume":"39","author":"Shi","year":"2000","journal-title":"Proteins"},{"key":"10.1016\/j.omtn.2023.06.023_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1042\/bj3540501","article-title":"Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes","volume":"354","author":"Shi","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2023.06.023_bib29","first-page":"51","article-title":"Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemia","volume":"8","author":"Darvish-Damavandi","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtn.2023.06.023_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2011.111","article-title":"Sustained correction of OTC deficiency in Spfash mice using optimized self-complementary AAV2\/8 vectors","volume":"5","author":"Wang","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2023.06.023_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2017.02.011","article-title":"AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice","volume":"120","author":"Wang","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2023.06.023_bib32","doi-asserted-by":"crossref","first-page":"21150","DOI":"10.1073\/pnas.1906182116","article-title":"Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency","volume":"116","author":"Truong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.023_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0006-291X(81)91790-3","article-title":"Site of synthesis and intracellular transport of the precursor of mitochondrial ornithine carbamoyltransferase","volume":"99","author":"Morita","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2023.06.023_bib34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/oxfordjournals.jbchem.a133158","article-title":"Processing of a putative precursor of rat liver ornithine transcarbamylase, a mitochondrial matrix enzyme","volume":"88","author":"Mori","year":"1980","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.omtn.2023.06.023_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/dna.1985.4.147","article-title":"The primary structure of the imported mitochondrial protein, ornithine transcarbamylase from rat liver: mRNA levels during ontogeny","volume":"4","author":"McIntyre","year":"1985","journal-title":"DNA"},{"key":"10.1016\/j.omtn.2023.06.023_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1432-1033.1982.tb06487.x","article-title":"A mitochondrial protease that cleaves the precursor of ornithine carbamoyltransferase. Purification and properties","volume":"122","author":"Miura","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtn.2023.06.023_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(82)80002-8","article-title":"Processing of pre-ornithine transcarbamylase requires a zinc-dependent protease localized to the mitochondrial matrix","volume":"105","author":"Conboy","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2023.06.023_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.510240219","article-title":"Development of the ornithine cycle in rat liver: zonation of a metabolic pathway","volume":"24","author":"Dingemanse","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2023.06.023_bib39","doi-asserted-by":"crossref","first-page":"24156","DOI":"10.1038\/srep24156","article-title":"PGC-1\u03b1 promotes ureagenesis in mouse periportal hepatocytes through SIRT3 and SIRT5 in response to glucagon","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.06.023_bib40","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.celrep.2017.11.081","article-title":"Systemic messenger RNA therapy as a treatment for methylmalonic acidemia","volume":"21","author":"An","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2023.06.023_bib41","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1038\/s41467-021-23318-2","article-title":"mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.06.023_bib42","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.06.023_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41422-022-00630-0","article-title":"Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters","volume":"32","author":"Deng","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2023.06.023_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-152827-0.50040-2","article-title":"Regulation of mitochondrial protein concentration: a plausible model which may permit assessing protein turnover","volume":"27","author":"Grisol\u00eda","year":"1985","journal-title":"Curr. Top. Cell. Regul."},{"key":"10.1016\/j.omtn.2023.06.023_bib45","doi-asserted-by":"crossref","first-page":"111953","DOI":"10.1016\/j.biopha.2021.111953","article-title":"Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2","volume":"142","author":"Granados-Riveron","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2023.06.023_bib46","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.06.023_bib47","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41598-022-05195-x","article-title":"Therapeutic enzyme engineering using a generative neural network","volume":"12","author":"Giessel","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.06.023_bib48","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1002\/ctd2.33","article-title":"Restoring ornithine transcarbamylase (OTC) activity in an OTC-deficient mouse model using LUNAR-OTC mRNA","volume":"2","author":"Yu","year":"2022","journal-title":"Clin. Transl. Discov."},{"key":"10.1016\/j.omtn.2023.06.023_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2023.06.023_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0363-4_6","article-title":"Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications","volume":"1141","author":"Walsh","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2023.06.023_bib51","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.str.2021.05.004","article-title":"Improving particle quality in cryo-EM analysis using a PEGylation method","volume":"29","author":"Zhang","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.omtn.2023.06.023_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2023.06.023_bib53","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1042\/BCJ20210708","article-title":"New tools for automated cryo-EM single-particle analysis in RELION-4.0","volume":"478","author":"Kimanius","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2023.06.023_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2023.06.023_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","article-title":"CTFFIND4: fast and accurate defocus estimation from electron micrographs","volume":"192","author":"Rohou","year":"2015","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.omtn.2023.06.023_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.omtn.2023.06.023_bib57","doi-asserted-by":"crossref","first-page":"107545","DOI":"10.1016\/j.jsb.2020.107545","article-title":"Mitigating local over-fitting during single particle reconstruction with SIDESPLITTER","volume":"211","author":"Ramlaul","year":"2020","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.omtn.2023.06.023_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1107\/S205225251801463X","article-title":"A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis","volume":"6","author":"Zivanov","year":"2019","journal-title":"IUCrJ"},{"key":"10.1016\/j.omtn.2023.06.023_bib59","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1073\/pnas.86.11.4142","article-title":"The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing","volume":"86","author":"Hodges","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.023_bib60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0003-2697(81)90594-7","article-title":"An improved colorimetric assay for aspartate and ornithine transcarbamylases","volume":"118","author":"Pastra-Landis","year":"1981","journal-title":"Anal. Biochem."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:37:42Z","timestamp":1761874662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"alternative-id":["S2162253123001737"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.06.023","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}